Improving the lives of patients and their
families through innovation.

Investor Relations

Overview

Neos Therapeutics is a pharmaceutical company focused on developing, manufacturing and commercializing innovative therapies utilizing our microparticle delivery technology. We are dedicated to developing life-changing medicines for patients and their families in need.

We are focused on creating shareholder value for Neos through growing our ADHD portfolio, diversifying our business and achieving operational excellence.

Investment Highlights

  • Three marketed ADHD products and a growing development pipeline Learn more
  • Experienced pharma commercial leadership and in-house salesforce
  • Innovative microparticle delivery technology Learn more

SEC Compliance Hotline

Report online: www.openboard.info/NEOS/ or Call toll-free: 844.375.8324 (24 hours a day, 7 days a week)
Anytime, from any location. You DO NOT have to give your name.